Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention.

Intern Med · 2019 · PMC6746638 · PMID 31118376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, prasugrel showed a trend toward fewer ischemic events than clopidogrel, and it had an acceptable safety profile in patients undergoing PCI as well as those with acute coronary syndrome in global as well as Japanese clinical trials ( 9 - 11 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.